Medicare Pilot Program Offers Cornbread Hemp Products to Patients
The Cornbread Hemp CBD pilot program marks a significant step in Medicare's coverage of hemp-derived cannabinoid products. This initiative could expand patient access to clinically evaluated CBD therapies. Medicare's involvement signals a shift toward…
GLP-1 Receptor Agonist Coverage: Sleep Apnea Legal Battle
GLP-1 insurance denial is a growing issue in the treatment of obesity-related sleep apnea. Legal battles are challenging payer restrictions on coverage for GLP-1 therapies. This evolving landscape affects clinicians and patients seeking access to these…
GLP-1 Receptor Agonist Costs: Insurance & Coverage 2026
GLP-1 receptor agonist insurance coverage varies widely in 2026, impacting patient access and adherence. Medicare Part D covers diabetes indications but often excludes obesity. Manufacturer savings programs can help reduce out-of-pocket costs for…
GLP-1 Medications Cost & Coverage Guide 2026
GLP-1 medications cost 2026 is a critical topic as Medicare expands coverage starting July 2026. This guide explains the anticipated changes in access and pricing for GLP-1 therapies. Clinicians and patients should prepare for new coverage policies…
CMS Announces 2.48% Medicare Advantage Payment Rate Increase for 2027
CMS has announced a 2.48% Medicare Advantage payment rate 2027 increase that affects coverage decisions. This increase influences insurer willingness to cover cannabis-related treatments. Understanding this Medicare Advantage payment rate 2027 change is…
A Health Technology Assessment of Medical Cannabis: Clinical and Economic Perspectives
Health technology assessment medical cannabis provides a rigorous evaluation of clinical efficacy and economic value. This assessment guides insurance coverage and formulary decisions. It represents a critical step toward integrating cannabis into…
High Tide Subsidiary NuLeaf Naturals Pursues Medicare CBD Pilot Program
Medicare CBD insurance coverage is gaining attention as NuLeaf Naturals pursues participation in a new pilot program. This development could transform access to CBD for millions of older adults. The pilot represents a potential shift in federal insurance…
High Tide Subsidiary NuLeaf Naturals Pursues Participation in U.S. Medicare CBD Pilot
Medicare CBD insurance coverage policy is evolving with a new pilot program including NuLeaf Naturals. This initiative marks a significant step toward federal recognition of cannabis therapeutics. It could improve access for Medicare beneficiaries facing…
Vlasic Labs CBD Products Qualify for CMS Pilot Program | Cannabis Business Times
Vlasic Labs CBD products have qualified for the CMS pilot program, signaling a key regulatory milestone. This CMS pilot program inclusion may influence insurance coverage and clinical practices. Clinicians should monitor this CMS pilot program as it…
Did Carrier have to Cough up Cash for THC Edibles of Worker with Chronic Pain?
Workers compensation medical cannabis coverage is evolving, especially for chronic pain cases involving THC edibles. This development impacts insurance decisions and patient access. Understanding these changes helps clinicians and patients navigate…
